Iressa
(Gefitinib)
(250 mg)
(thirty)
(Tablets)
Iressa (gefitinib) 250 mg 30 tabs ASTRA ZENEKA UK
Article:
Possible spelling: iresa, iresa, iresa, iresa, heresa, heresa.
Indications
- Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations in epidermal growth factor receptor tyrosine kinase
-
Commercial name:Iressa
-
Сhemical name:Gefitinib
-
Dosage:250 mg
-
Quantity:thirty
-
Release form:Tablets
-
Производитель:Астра Зенека
No reviews yet